293 related articles for article (PubMed ID: 8651844)
41. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
[TBL] [Abstract][Full Text] [Related]
42. Herpes zoster in juvenile-onset systemic lupus erythematosus: incidence, clinical characteristics and risk factors.
Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
Pediatr Infect Dis J; 2006 Aug; 25(8):728-32. PubMed ID: 16874173
[TBL] [Abstract][Full Text] [Related]
43. [Survival rates in patients with systemic lupus erythematosus].
Xie S; Feng S; Fu H
Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):617-20. PubMed ID: 8697080
[TBL] [Abstract][Full Text] [Related]
44. Lupus anticoagulant in Thai systemic lupus erythematosus patients.
Intragumtornchai T; Akkawat B; Mahasandana S; Watananukul P; Deesomchok U
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():241-5. PubMed ID: 7886586
[TBL] [Abstract][Full Text] [Related]
45. [An analysis of the survival of 120 male patients with systemic lupus erythematosus].
Folomeev MIu; Alekberova ZS
Revmatologiia (Mosk); 1990; (4):17-9. PubMed ID: 2075348
[TBL] [Abstract][Full Text] [Related]
46. Poly(ADP-ribose) polymerase (PARP) polymorphisms associated with nephritis and arthritis in systemic lupus erythematosus.
Hur JW; Sung YK; Shin HD; Park BL; Cheong HS; Bae SC
Rheumatology (Oxford); 2006 Jun; 45(6):711-7. PubMed ID: 16461442
[TBL] [Abstract][Full Text] [Related]
47. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia.
Al Arfaj AS; Khalil N
Lupus; 2009 Apr; 18(5):465-73. PubMed ID: 19318403
[TBL] [Abstract][Full Text] [Related]
48. Clinical significance of low molecular weight IgM in patients with systemic lupus erythematosus.
Harisdangkul V; Barnes TY; Songcharoen S; Pennebaker JB
J Rheumatol; 1984 Oct; 11(5):638-43. PubMed ID: 6334743
[TBL] [Abstract][Full Text] [Related]
49. Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment.
Foocharoen C; Nanagara R; Suwannaroj S; Mahakkanukrauh A
Int J Rheum Dis; 2011 Oct; 14(4):353-60. PubMed ID: 22004232
[TBL] [Abstract][Full Text] [Related]
50. [Mortality characteristics in people with systemic lupus erythematosus].
Mayer M
Reumatizam; 2009; 56(2):44-9. PubMed ID: 20429262
[TBL] [Abstract][Full Text] [Related]
51. Systemic lupus erythematosus in men: a multivariate analysis of gender differences in clinical manifestations.
Ward MM; Studenski S
J Rheumatol; 1990 Feb; 17(2):220-4. PubMed ID: 2319521
[TBL] [Abstract][Full Text] [Related]
52. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population.
Mok CC; Lee KW; Ho CT; Lau CS; Wong RW
Rheumatology (Oxford); 2000 Apr; 39(4):399-406. PubMed ID: 10817773
[TBL] [Abstract][Full Text] [Related]
53. Criteria for the classification of systemic lupus erythematosus--status 1972.
Cohen AS; Canoso JJ
Arthritis Rheum; 1972; 15(5):540-3. PubMed ID: 4117792
[No Abstract] [Full Text] [Related]
54. An evaluation of the preliminary criteria for the diagnosis of systemic lupus erythematosus.
Lie TH; Rothfield NF
Arthritis Rheum; 1972; 15(5):532-4. PubMed ID: 4117791
[No Abstract] [Full Text] [Related]
55. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.
Min HK; Lee JH; Jung SM; Lee J; Kang KY; Kwok SK; Ju JH; Park KS; Park SH
Korean J Intern Med; 2015 Mar; 30(2):232-41. PubMed ID: 25750566
[TBL] [Abstract][Full Text] [Related]
56. Clinical implications and prognostic significance of thrombocytopenia in Tunisian patients with systemic lupus erythematosus.
Jallouli M; Frigui M; Marzouk S; Snoussi M; Kechaou M; Kaddour N; Masmoudi H; Elloumi M; Bahloul Z
Lupus; 2012 May; 21(6):682-7. PubMed ID: 22354537
[TBL] [Abstract][Full Text] [Related]
57. [Systemic lupus erythematosus. 2. Factors of predictive significance for survival].
Halberg P; Bendixen G; Fugleberg S; Jørgensen F; Kriegbaum NJ; Lorenzen I; Müller K; Olesen KM; Rasmussen E; Ullman S
Ugeskr Laeger; 1991 Jun; 153(24):1705-9. PubMed ID: 2058039
[TBL] [Abstract][Full Text] [Related]
58. Prognostically distinct clinical patterns of systemic lupus erythematosus identified by cluster analysis.
To CH; Mok CC; Tang SS; Ying SK; Wong RW; Lau CS
Lupus; 2009 Dec; 18(14):1267-75. PubMed ID: 19861343
[TBL] [Abstract][Full Text] [Related]
59. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.
Parodi A; Davì S; Pringe AB; Pistorio A; Ruperto N; Magni-Manzoni S; Miettunen P; Bader-Meunier B; Espada G; Sterba G; Ozen S; Wright D; Magalhães CS; Khubchandani R; Michels H; Woo P; Iglesias A; Guseinova D; Bracaglia C; Hayward K; Wouters C; Grom A; Vivarelli M; Fischer A; Breda L; Martini A; Ravelli A;
Arthritis Rheum; 2009 Nov; 60(11):3388-99. PubMed ID: 19877067
[TBL] [Abstract][Full Text] [Related]
60. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus.
Sibley JT; Olszynski WP; Decoteau WE; Sundaram MB
J Rheumatol; 1992 Jan; 19(1):47-52. PubMed ID: 1556699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
